{"id":"https://openalex.org/W1968219530","doi":"https://doi.org/10.1111/1467-9310.00212","title":"Evaluating growth options as sources of value for pharmaceutical research projects","display_name":"Evaluating growth options as sources of value for pharmaceutical research projects","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W1968219530","doi":"https://doi.org/10.1111/1467-9310.00212","mag":"1968219530"},"language":"en","primary_location":{"id":"doi:10.1111/1467-9310.00212","doi":"https://doi.org/10.1111/1467-9310.00212","is_oa":false,"landing_page_url":"https://doi.org/10.1111/1467-9310.00212","pdf_url":null,"source":{"id":"https://openalex.org/S43637407","display_name":"R and D Management","issn_l":"0033-6807","issn":["0033-6807","1467-9310"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","fnege-2","jufo-2","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"R&D Management","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057530873","display_name":"Christoph H. Loch","orcid":"https://orcid.org/0000-0002-6569-7473","observed_orcids":["https://orcid.org/0000-0002-6569-7473"]},"institutions":[{"id":"https://openalex.org/I102272798","display_name":"INSEAD","ror":"https://ror.org/00ghzk478","country_code":"FR","type":"education","lineage":["https://openalex.org/I102272798"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christoph H. Loch","raw_affiliation_strings":["INSEAD, Boulevard de Constance, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSEAD, Boulevard de Constance, France","institution_ids":["https://openalex.org/I102272798"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015558130","display_name":"Kerstin M. Bode-Greuel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kerstin Bode\u2010Greuel","raw_affiliation_strings":["Bioscience Valuation GmbH, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Valuation GmbH, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":4.5165,"has_fulltext":false,"cited_by_count":114,"citation_normalized_percentile":{"value":0.94836564,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"31","issue":"2","first_page":"231","last_page":"248"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10067","display_name":"Stochastic processes and financial applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/growth-options","display_name":"growth options","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pharmaceutical-research-and-development","display_name":"pharmaceutical R&D","score":0.7699999809265137},{"id":"https://openalex.org/keywords/r-d-project-evaluation","display_name":"R&D project evaluation","score":0.7680000066757202},{"id":"https://openalex.org/keywords/decision-tree","display_name":"decision tree","score":0.8190000057220459},{"id":"https://openalex.org/keywords/managerial-flexibility","display_name":"managerial flexibility","score":0.9580000042915344},{"id":"https://openalex.org/keywords/strategic-innovation","display_name":"strategic innovation","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.713927149772644},{"id":"https://openalex.org/C194483076","wikidata":"https://www.wikidata.org/wiki/Q380382","display_name":"Valuation of options","level":2,"score":0.5323144793510437},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5225107669830322},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4993455410003662},{"id":"https://openalex.org/C181230689","wikidata":"https://www.wikidata.org/wiki/Q192472","display_name":"Net present value","level":3,"score":0.4981498718261719},{"id":"https://openalex.org/C76178495","wikidata":"https://www.wikidata.org/wiki/Q4808784","display_name":"Asset (computer security)","level":2,"score":0.4292455017566681},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.37993407249450684},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.3644448518753052},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.3616839647293091},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.34444496035575867},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.29712051153182983},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.22701752185821533},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.0},{"id":"https://openalex.org/C2778348673","wikidata":"https://www.wikidata.org/wiki/Q739302","display_name":"Production (economics)","level":2,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/1467-9310.00212","doi":"https://doi.org/10.1111/1467-9310.00212","is_oa":false,"landing_page_url":"https://doi.org/10.1111/1467-9310.00212","pdf_url":null,"source":{"id":"https://openalex.org/S43637407","display_name":"R and D Management","issn_l":"0033-6807","issn":["0033-6807","1467-9310"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","fnege-2","jufo-2","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"R&D Management","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"display_name":"Industry, innovation and infrastructure","score":0.6200000047683716,"id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1784952204","https://openalex.org/W7111680000","https://openalex.org/W7099200580","https://openalex.org/W648807472","https://openalex.org/W2737475305","https://openalex.org/W2171423430","https://openalex.org/W2068976092","https://openalex.org/W1995807338","https://openalex.org/W7045517815","https://openalex.org/W4412908601"],"abstract_inverted_index":{"The":[0,80,237],"financial":[1,91,177,199],"value":[2,31,301],"of":[3,82,116,123,153,181,209,248,271,278,291,332],"research":[4,124,214,283],"projects":[5,125],"is":[6,18,70,106,143,164,183,225],"difficult":[7],"to":[8,24,64,147,157,166,244,296,313,325],"assess":[9],"because":[10],"they":[11,328],"are":[12,126,195],"highly":[13],"uncertain.":[14],"Often,":[15],"the":[16,109,117,120,154,176,245,249,276,292,310,322],"result":[17],"either":[19],"an":[20,34],"overly":[21,35],"conservative":[22],"approach":[23,37],"strategic":[25,282,303],"innovation,":[26],"based":[27,38],"on":[28,39],"net":[29],"present":[30],"analyses,":[32],"or":[33,252],"aggressive":[36],"optimistic":[40],"qualitative":[41],"portfolios.":[42],"R&D":[43,235,250],"project":[44,128,272,300],"evaluation":[45,208],"requires":[46],"recognizing":[47],"threats":[48],"as":[49,51],"well":[50],"opportunities":[52],"from":[53,213,232],"uncertain":[54],"events,":[55],"and":[56,130,156,186,192,302,324],"incorporating":[57],"flexibility":[58,193],"in":[59,62,86,93,112,134,175,198,321],"managerial":[60,78,149],"action":[61],"response":[63],"them.":[65],"Real":[66],"options":[67,83,150,167,212,264],"pricing":[68,84,168],"analysis":[69],"a":[71,95,140,144,206,217,226,233,268,287],"widely":[72],"discussed":[73],"tool":[74,146],"for":[75,89,169,267],"evaluating":[76],"such":[77],"flexibility.":[79],"limitation":[81],"lies":[85],"its":[87,159],"requirement":[88],"complete":[90],"markets,":[92],"which":[94,294],"replicating":[96],"asset":[97],"can":[98,172,189],"be":[99,132,173,242,255],"found":[100],"that":[101,171,194,229,262,327],"reproduces":[102],"(or,":[103],"at":[104,215],"least,":[105],"correlated":[107],"with)":[108],"project\u2019s":[110],"payoffs":[111],"all":[113],"possible":[114],"states":[115],"world.":[118],"However,":[119],"major":[121,330],"risks":[122,170,191],"typically":[127],"specific":[129],"cannot":[131],"replicated":[133],"external":[135],"markets.":[136,200],"In":[137],"this":[138],"situation,":[139],"decision":[141,162,202,288],"tree":[142,163,289,311],"better":[145],"represent":[148],"during":[151],"execution":[152],"project,":[155,251],"evaluate":[158],"value.":[160,273,333],"A":[161,222],"equivalent":[165],"priced":[174],"markets":[178],"(if":[179],"trading":[180],"securities":[182],"explicitly":[184],"included),":[185],"moreover,":[187],"it":[188],"incorporate":[190],"not":[196,241,253],"traded":[197],"Using":[201],"trees,":[203],"we":[204],"demonstrate":[205],"quantitative":[207],"compound":[210],"growth":[211,223,238,263,315],"BestPharma,":[216],"large":[218,269],"international":[219],"pharmaceutical":[220],"company.":[221],"option":[224,239],"future":[227],"opportunity":[228],"may":[230,240,265],"arise":[231],"current":[234],"investment.":[236],"related":[243],"primary":[246],"purpose":[247],"even":[254],"directly":[256],"foreseeable.":[257],"Kester":[258],"(1984)":[259],"has":[260],"argued":[261],"account":[266],"part":[270],"BestPharma":[274],"faced":[275],"problem":[277],"choosing":[279],"among":[280],"several":[281],"initiatives.":[284],"They":[285],"developed":[286],"representation":[290],"projects,":[293],"helped":[295,312],"provide":[297],"transparency":[298],"about":[299],"options.":[304],"Most":[305],"importantly,":[306],"carefully":[307],"thinking":[308],"through":[309],"identify":[314],"options,":[316],"represented":[317,329],"by":[318],"additional":[319],"branches":[320],"tree,":[323],"quantify":[326],"sources":[331]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}